RJF: Laboratorio Reig Jofre, S.A. - Summary | Jitta

Laboratorio Reig Jofre, S.A.

ESP:RJF

Price
€2.77
Loss Chance
49.1%
4.16JITTA SCORE
53.30%Over Jitta Line
Jitta Ranking
101 / 139
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (44)
Recent Business Performance (37)
Financial Strength (78)
Return to Shareholders (0)
Competitive Advantage (32)
Jitta Signs
Revenue and EarningEarning decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 49.28% in the last year
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
4.16
53.30%
4.95
137.94%
4.64
105.67%
Pharmaceuticals
4.72
231.00%
5.46
68.50%
5.47
198.95%
COMPANY DESCRIPTION
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.